Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gilead Sciences International Ltd
Woman and Man Max 99 years
Gilead Sciences International Ltd
Update Il y a 4 ans
Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxicity in Chronic Hepatitis B (CHB)-infected adolescents aged 12 to <18 years in Europe
To characterize the long term (i.e., 96 weeks of follow up) bone safety profile of open-label Tenofovir DF treatment in CHB infected adolescents. This includes prospectively evaluating and comparing ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences International Ltd
Update Il y a 4 ans
FINITE CHB – A study investigating stopping Viread therapy in long term treated Hepatitis B patients
The primary objective of the study is to evaluate HBsAg loss and seroconversion in subjects who stop tenofovir disoproxil fumarate (TDF) (Arm A) compared to subjects who continue TDF (Arm B)
Country
None
organs
None
Specialty
None
Closed trial
More information